Skip to content

Intra- and post-operative analgesia for patients undergoing surgery for hip fracture - role of Fascia Illiaca Compartment Block

Intra- and post-operative analgesia for patients undergoing surgery for hip fracture - role of Fascia Illiaca Compartment Block

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN75659782
Enrollment
40
Registered
2007-09-28
Start date
2006-04-04
Completion date
Unknown
Last updated
2017-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery: Analgesia Surgery Analgesia

Interventions

Purpose: To see whether analgesic efficacy of Fascia Iliaca Compartment Block (FICB) is better than that of Morphine during and post hip fracture surgery Theoretical framework: The commonly used nerv

Sponsors

Record Provided by the NHSTCT Register - 2007 Update - Department of Health
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All adult ASA physical status 1, 2 and 3 patients with hip fracture posted for DHS or cannulated screw fixation

Exclusion criteria

Exclusion criteria: 1. Dementia/confusion as it is difficult to assess pain relief 2. Pre-operative chest infection and/or poor respiratory function - Temperature 380C or more, white cell count> 11000 mm3, Respiratory rate > 25 per minute, auscultation and or chest x-ray evidence, Sp02 < 90 % on air 3. Congestive Cardiac Failure (CCF) 4. Bed bound or use of 2 or more aids for mobilisation pre-fracture 5. Malignancy 6. Coagulopathy 7. Known or suspected allergy to Ropivacaine and/or Morphine 8. Local infection at the site where the block is to be performed 9. Refusal of permission to approach General Practitioner Justification for these exclusion criteria: Pre-fracture poor mental status, poor mobility, CCF, poor respiratory function and malignancy are independent risk factors for poor outcome following hip fracture The morbidity and mortality in this group is high and unlikely to be influenced by choice of technique. The others are standard contra-indications for any nerve block technique.

Design outcomes

Primary

MeasureTime frame
Total dose of morphine required during first 24 hours post-op

Secondary

MeasureTime frame
1. Time to first dose of morphine post-op 2. Pain scores in recovery room and at 13, 16 and 24 hours post-op, intra- and inter-group analysis 3. Time to first appropriate response to verbal commands post-op 4. Time to discharge from recovery room 5. Occurrence of nausea and vomiting in recovery and no. of episodes during the first 24 hours post-op 6. Total dose of Cyclizine required in the first 24 hours post-op. 7. Need for Granisetron during the first 24 hours post-op. 8. Sedation Scores at 1,3,6 and 24 hours post-op. 9. Mental Test Scores at 1,3,6 and 24 hours post-op. compared to pre-op score, intra- and inter-group analysis. 10. Other: unlikely to find significant difference because of sample size but full reporting of morbidity, complications, rehabilitation outcomes and mortality will be useful. There has been no involvement of patient groups, research participants or communities in the design of this study.

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026